Candriam S.C.A.Candriam S.C.A.

Institutional investor · Portfolio as of Q4 2022

Top Holdings860 positions

Checking export access…
Activity:

MICROSOFT CORP

3.2M$773.2M5.2%$174.62+33.29%
16 qtrssince 2019-Q1
Increased
62

APPLE INC

4.4M$572.1M3.9%$99.95+27.72%
16 qtrssince 2019-Q1
Decreased
0

ALPHABET INC

4.1M$365.9M2.5%$71.51+22.22%
16 qtrssince 2019-Q1
Increased
53

MERCK & CO INC

3.2M$355.7M2.4%$66.01+50.29%
16 qtrssince 2019-Q1
Decreased
0

REGENERON PHARMACEUTICALS

382,968$276.3M1.9%$490.54+45.71%
16 qtrssince 2019-Q1
Decreased
0

UNITEDHEALTH GROUP INC

492,275$261M1.8%$350.20+40.54%
16 qtrssince 2019-Q1
Increased
49

AMGEN INC

979,786$257.3M1.7%$175.07+33.57%
16 qtrssince 2019-Q1
Increased
49

DANAHER CORPORATION

944,363$250.6M1.7%$176.35+30.65%
16 qtrssince 2019-Q1
Increased
52

THERMO FISHER SCIENTIFIC INC

439,194$241.8M1.6%$412.61+31.91%
16 qtrssince 2019-Q1
Increased
50

PROCTER AND GAMBLE CO

1.5M$224.1M1.5%$111.92+22.81%
16 qtrssince 2019-Q1
Decreased
0

ELI LILLY & CO

537,869$196.8M1.3%$243.67+45.91%
16 qtrssince 2019-Q1
Decreased
0

VISA INC

788,290$163.8M1.1%$177.80+13.55%
16 qtrssince 2019-Q1
Increased
51

GILEAD SCIENCES INC

1.6M$140.3M0.9%$50.05+51.61%
16 qtrssince 2019-Q1
Decreased
0

ALPHABET INC

1.6M$139.8M0.9%$87.90-0.01%
16 qtrssince 2019-Q1
Increased
45

VERTEX PHARMACEUTICALS INC

469,145$135.5M0.9%$204.70+41.07%
16 qtrssince 2019-Q1
Decreased
0

MASTERCARD INCORPORATED

360,332$125.3M0.8%$285.29+19.18%
16 qtrssince 2019-Q1
Increased
44

DARLING INGREDIENTS INC

2M$124.6M0.8%$66.26-5.54%
8 qtrssince 2021-Q1
Increased
57

JOHNSON & JOHNSON

691,056$122.1M0.8%$136.81+16.00%
16 qtrssince 2019-Q1
Increased
56

BANK AMERICA CORP

3.6M$118.5M0.8%$30.46-1.07%
16 qtrssince 2019-Q1
Decreased
0

AMAZON COM INC

1.4M$117.7M0.8%$105.65-20.50%
16 qtrssince 2019-Q1
Increased
50
$14.8B
AUM
860
Positions
Q4 2022
Filing
HI score · 2.5/5
Quarterly 13F Value Change
+1%Q3'21$14.7B+7%Q4'21$15.7B-6%Q1'22$14.7B-17%Q2'22$12.1B+17%Q3'22$14.2B+4%Q4'22$14.8B
Activity profile
$ moved · Q4'22
New5%Increased50%Decreased38%Exited7%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 years
<1Q4%1-4Q14%1-2Y10%2Y+72%

Candriam S.C.A. manages $14.8B across 860 positions as of Q4 2022. Top holdings: MSFT (5.2%), AAPL (3.9%), GOOGL (2.5%). Fund DNA: Steady Compounder. HoldingsIntel Score: 2.5/5.0.

Q4 2022 Summary

Active quarter - 58 new positions, 67 exits, 279 increased. Top move: MSFT (INCREASED, conviction 62). Portfolio: $14.8B across 860 positions.

Top holdings by portfolio weight

Total AUM$15B
MSFT5.22%
AAPL3.86%
GOOGL2.47%
MRK2.40%
REGN1.86%
UNH1.76%
AMGN1.74%
DHR1.69%
TMO1.63%
PG1.51%
Other1.33%

Portfolio allocation by GICS sector

Sectors11
Healthcare31.40%
Technology22.48%
Financial Services9.90%
Consumer Cyclical7.65%
Industrials7.54%
Consumer Defensive5.62%
Communication Services5.48%
Unknown3.78%
Real Estate2.12%
Basic Materials1.62%
Other2.41%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L59
Conviction42
Concentration49
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
AEMAEMAGNICO EAGLE MINES LTD
Q4 2024 → Q2 2026+365,880 shares+$57.5M
7Q
AMZNAMZNAmazon.com, Inc.
Q4 2024 → Q2 2026+784,807 shares+$280.6M
7Q
CCCITIGROUP INC
Q4 2024 → Q2 2026+275,487 shares+$52.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used